Can-Fite BioPharma Ltd. Gains 26.92%

Thu 05 Mar 20 at 05:30 PM
Can-Fite BioPharma Ltd. Gains 26.92%

Can-Fite BioPharma Ltd. (CANF:NYSEMKT) shot up at $1.98, representing a gain of 26.9%. On Wed 04 Mar 20, CANF:NYSEMKT hit a New 2-Week Intraday High of $1.79. The stock got featured on our News Catalysts scanner on Thu 05 Mar 20 at 04:24 AM in the 'RECOMMENDATION' category. From Wed 19 Feb 20, the stock recorded 40.00% Up Days and 27.27% Green Days

The share price of the company has been moving sideways in recent weeks.

About Can-Fite BioPharma Ltd. (CANF:NYSEMKT)

Can Fite Biofarma Ltd is a clinical stage biopharmaceutical company. It develops orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases.